Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidiolex for Cognitive Impairment in Sturge-Weber Syndrome
NCT04447846Phase 2Completed
- Start
- Oct 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in Sturge-Weber syndrome (SWS). Started Oct 2019; status: completed.
02
Drugs
cannabidiol
03
Conditions
Sturge-Weber syndrome (SWS)
Beyond the preview
Go deeper on NCT04447846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04447846.